NYSE · AGL
agilon health, inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AGL: Nov 04, 2026
agilon health, inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-2.01. The reported EPS for the same quarter last year was $-6.75.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-2.01 | $-1.08 | $-3.44 | 3 |
| Dec 2026 | $-3.65 | $-3.12 | $-4.12 | 3 |
| Mar 2027 | $1.78 | $1.78 | $1.78 | 1 |
| Jun 2027 | $3.84 | $3.84 | $3.84 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · BNK Invest · The Motley Fool- Zacks · Oct 23, 8:40 AM EDTAre Medical Stocks Lagging Agilon Health (AGL) This Year?Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
- Zacks · Oct 7, 8:40 AM EDTIs Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?Here is how Agilon Health (AGL) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.
- RTTNews · Sep 25, 2:41 PM EDT5 Biotech Stocks Making Headlines – ADRX, CNSY, JAGX, AGL, ONCO(RTTNews) – The following biotech and healthcare-related stocks were in focus on September 25, 2026, following developments including an initial public offering, diagnostic reimbursement expansion, regulatory fee waivers, value-based care expansion and portfolio investment change
- BNK Invest · Sep 24, 4:38 PM EDTAgilon Health is Now Oversold (AGL)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
- Zacks · Aug 28, 9:40 AM EDTIs Agilon Health (AGL) Outperforming Other Medical Stocks This Year?Here is how Agilon Health (AGL) and Illumina (ILMN) have performed compared to their sector so far this year.
- The Motley Fool · Aug 12, 8:31 PM EDTAgilon Health (AGL) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 12, 9:40 AM EDTHas Agilon Health (AGL) Outpaced Other Medical Stocks This Year?Here is how Agilon Health (AGL) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
- MarketBeat · Aug 6, 4:04 AM EDTAgilon Health Q2 Earnings Call HighlightsAgilon Health (NYSE:AGL) reported second-quarter results that exceeded its guidance for medical margin and adjusted EBITDA, citing stronger risk-adjustment revenue, favorable medical-cost development and progress in its clinical and quality initiatives. The company also raised it
- RTTNews · Aug 6, 3:13 AM EDTAgilon Health Swings To Q2 Net Profit; Guides For Q3;Lifts 2026 Revenue View; Stock Gains(RTTNews) – Agilon Health (AGL), which provides healthcare services for seniors, reported financial results for the second quarter of 2026, swinging to net profit from loss last year. In addition, the company provided revenue guidance for the third quarter and raised revenue guid
- Zacks · Aug 5, 8:35 PM EDTAgilon Health (AGL) Tops Q2 Earnings and Revenue EstimatesAgilon (AGL) delivered earnings and revenue surprises of +1,633.33% and +3.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 8:30 PM EDTAgilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- RTTNews · Jul 17, 5:13 AM EDTBiotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVN(RTTNews) – The following biotech stocks reached 52-week highs on July 16, 2026, resulting due to anticipated quarterly report releases or an upcoming conference participation.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for agilon health, inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.